What is the total market value of Glycomics Market report?
Expected Revenue Growth:
[173 Pages Report] The global glycomics market is estimated
to grow from USD 1.0 billion in 2020 to USD 2.0 billion by 2025, at a CAGR of
13.8%.
Download PDF Brochure:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=132685525
What This Report Will Provide?
This study involved four major activities in estimating the
current size of the glycomics market. Exhaustive secondary research was carried
out to collect information on the market, its peer markets, and its parent
market.
The next step was to validate these findings, assumptions,
and sizing with industry experts across the value chain through primary
research. The bottom-up approach was employed to estimate the size of the
market.
Major Growth Boosters:
The growth of this market is majorly driven by the
increasing R&D expenditure and funding for proteomics and glycomics
research, growth of the proteomics market, and technological advancements in
glycomics instrumentation are the major factors driving the growth of the
glycomics market.
Regional Growth Analysis:
The global glycomics market is segmented into North America
(US and Canada), Europe (Germany, the UK, France, Italy, Spain, and the Rest of
Europe), Asia Pacific (Japan, China, India, Australia, and the Rest of Asia
Pacific), and the Rest of the World (Latin America and the Middle East and
Africa). In 2020, North America is expected to dominate the global glycomics
market, followed by Europe. The largest share of North America is mainly
attributed to increasing funding on glycomics research, rising R&D
expenditure for drug discovery & development, and the presence of all key
players.
Key Market Players
The prominent players operating in the glycomics market
include Merck KGaA (Germany), Agilent Technologies (US), Thermo Fisher
Scientific (US), New England Biolabs (US), Shimadzu Corporation (Japan), Takara
Bio (Japan), S-BIO (subsidiary of Sumitomo Bakelite Co. Ltd., Japan), Waters
Corporation (US), Asparia Glycomics S.L. (Spain), Bio-Techne (US), Bruker
Corporation (US), Danaher Corporation (US), RayBiotech (US), Z Biotech (US),
Chemily Glycoscience (US), Dextra Laboratories (UK), Lectenz Bio (US), and
Ludger Ltd. (UK).
Recent Developments
·
Agilent Technologies (US) has launched
InfinityLab LC/MSD iQ System
·
Thermo Fisher Scientific (US) had launched UHMR
Hybrid Quadrupole-Orbitrap Mass Spectrometer.
Key Questions Addressed by the Report
1.
Where will all these developments take the
industry in the mid-to-long term?
2.
What are the recent trends affecting the
glycomics market?
3.
Who are the key players in the market, and how
intense is the competition?
4.
What are the key applications of glycomics?
5.
Which region is lucrative for the market?
Request Sample Report: https://www.marketsandmarkets.com/requestsampleNew.asp?id=132685525
.webp)
Comments
Post a Comment